Page 138 - 《中国药房》2022年19期

[ 8 ] MARDANI A，JUSOH A，ZAVADSKAS E K，et al. Pro‐ 2021，39（1）：73-82.
posing a new hierarchical framework for the evaluation of [20] HWANG C L，KP Y. Multiple attribute decision making.
quality management practices：a new combined fuzzy hy‐ Methods and applications. A state-of-the-art survey[EB/
brid MCDM approach[J]. J Bus Econ Manag，2016，17 OL].[2022-02-10] https：//link.springer.com/book/10.1007/
（1）：1-16. 978-3-642-48318-9.
[ 9 ] BORDBAR M，AGHAMOHAMMADI H，POURGHASEMI [21] FORESTAL R L，PI S M. A hybrid approach based on
H R，et al. Multi-hazard spatial modeling via ensembles of ELECTRE Ⅲ-genetic algorithm and TOPSIS method for
machine learning and meta-heuristic techniques[J]. Sci selection of optimal COVID-19 vaccines[J]. J Multi Crite‐
Rep，2022，12（1）：1451. ria Decis Anal，2022，29（1/2）：80-91.
[10] CINELLI M，SPADA M，KIM W，et al. MCDA index [22] ZOLFANI S，ŠAPARAUSKAS J. New application of
tool：an interactive software to develop indices and ran- SWARA method in prioritizing sustainability assessment
kings[J]. Environ Syst Decis，2021，41（1）：82-109. indicators of energy system[J]. Eng Econ，2014，24：
[11] NICKLIN D，GOHARI DARABKHANI H. Techniques to 408-414.
measure particulate matter emissions from stationary [23] KAZANCOGLU Y，OZBILTEKIN-PALA M，SEZER M
sources：a critical technology review using multi criteria D，et al. Circular dairy supply chain management through
decision analysis（MCDA）[J]. J Environ Manage，2021， internet of things-enabled technologies[J]. Environ Sci
296：113167. Pollut Res Int，2022.
[12] WONDER M，DUNLOP S. Assessment of the quality of [24] EGHBALI-ZARCH M，TAVAKKOLI-MOGHADDAM
the clinical evidence in submissions to the Australian phar‐ R，ESFAHANIAN F，et al. Pharmacological therapy selec‐
maceutical benefits advisory committee：fit for purpose? tion of type 2 diabetes based on the SWARA and modified
[J]. Value Health，2015，18（4）：467-476. MULTIMOORA methods under a fuzzy environment[J].
[13] RAWLINS M D，CULYER A J. National Institute for Artif Intell Med，2018，87：20-33.
Clinical Excellence and its value judgments[J]. BMJ， [25] WEN Z，LIAO H C，REN R X，et al. Cold chain logistics
2004，329（7459）：224-227. management of medicine with an integrated multi-criteria
[14] YOUNGKONG S，BALTUSSEN R，TANTIVESS S，et decision-making method[J]. Int J Environ Res Public
al. Multicriteria decision analysis for including health in‐ Health，2019，16（23）：4843.
terventions in the universal health coverage benefit pa- [26] JAFARZADEH S，DOROSTI S，AB RAHMAN M N，
ckage in Thailand[J]. Value Health，2012，15（6）：961-970. et al. Theory-based failure modes and effect analysis for
[15] THOKALA P，DEVLIN N，MARSH K，et al. Multiple cri‐ medication errors[J]. J Healthc Eng，2021，2021：5533208.
teria decision analysis for health care decision making：an [27] IGHRAVWE D E，OKE S A. An integrated approach of
introduction：report 1 of the ISPOR MCDA emerging SWARA and fuzzy COPRAS for maintenance techni‐
good practices task force[J]. Value Health，2016，19（1）： cians’selection factors ranking[J]. Int J Syst Assur Eng
1-13. Manag，2019，10（6）：1615-1626.
[16] MACCRIMMON K R. Decision making among multiple- [28] BALKI M K，ERDOĞAN S，AYDIN S，et al. The optimi‐
attribute alternatives：a survey and consolidated approach zation of engine operating parameters via SWARA and
[M].Santa Monica：The RAND Corporation，1968：13-15. ARAS hybrid method in a small SI engine using alterna‐
[17] GENG X L，QIU H Q. Group decision-making method of tive fuels[J]. J Clean Prod，2020，258：120685.
design concept based on hesitant fuzzy PROMETHEE Ⅱ [29] MARDANI A，NILASHI M，ZAKUAN N，et al. A syste-
[J]. Application Research of Computers，2018，35（10）： matic review and meta-analysis of SWARA and WASPAS
3020-3024. methods：theory and applications with recent fuzzy deve-
[18] SAATY R W. Decision-making in complex environments： lopments[J]. Appl Soft Comput，2017，57：265-292.
the analytic hierarchy process（AHP）for decision-making [30] GHORSHI NEZHAD M R， ZOLFANI S H，
and the analytic network process （ANP） for decision- MOZTARZADEH F，et al. Planning the priority of high
making with dependence and feedback[EB/OL]. [2022-02- tech industries based on SWARA-WASPAS methodology：
30]. http：//www. rwspublications. com/app/download/561- the case of the nanotechnology industry in Iran[J]. Econ
417304/Tutorial2003.pdf. Res Ekon Istraživanja，2015，28（1）：1111-1137.
[19] MAKAN A，FADILI A. Sustainability assessment of （收稿日期：2022-03-30 修回日期：2022-08-24）
healthcare waste treatment systems using surrogate （编辑：刘明伟）
weights and PROMETHEE method[J]. Waste Manag Res，

·2432· China Pharmacy 2022 Vol. 33 No. 19 中国药房 2022年第33卷第19期